Cytokeratin 7 / Keratin K7 Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Cytokeratin 7 / Keratin K7 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Cytokeratin 7 / Keratin K7 |
| Clone | OVTL12/30 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | unconjugated |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Flow Cytometry, Immunocytochemistry, Immunohistochemistry (frozen), Immunohistochemistry (paraffin), Western Blotting |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Mouse anti Cytokeratin 7 / Keratin K7 |
| Immunogen | n/a |
| Other Names | n/a |
| Gene, Accession # | UniProt: P08729 |
| Catalog # | MUB0316P |
| Price | $402 |
| Order / More Info | Cytokeratin 7 / Keratin K7 Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Ramaekers, F., van Niekerk, C., Poels, L., Schaafsma, E., Huijsmans, A., Robben, H., Schaart, G., and Vooijs, P. (1990). Use of monoclonal antibodies to Keratin 7 in the differential diagnosis of adenocarcinomas, Am J Pathol 136, 641-55. 2. van Niekerk, C. C., Jap, P. H., Ramaekers, F. C., van de Molengraft, F., and Poels, L. G. (1991). Immunohistochemical demonstration of Keratin 7 in routinely fixed paraffin-embedded Human tissues, J Pathol 165, 145-52. 3. van Niekerk, C. C., Boerman, O. C., Ramaekers, F. C., and Poels, L. G. (1991). Marker profile of different phases in the transition of normal Human ovarian epithelium to ovarian carcinomas, Am J Pathol 138, 455-63. 4. van de Molengraft, F. J., van Niekerk, C. C., Jap, P. H., and Poels, L. G. (1993). OV-TL 12/30 (Keratin 7 antibody) is a marker of glandular differentiation in lung cancer, Histopathology 22, 35-8. 5. van Niekerk, C. C., Vooijs, P., Casparie-van Velsen, I. J., and Poels, L. G. (1997). Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies, Cancer Detect Prev 21, 247-57. 6. Torenbeek, R., Lagendijk, J. H., Van Diest, P. J., Bril, H., van de Molengraft, F. J., and Meijer, C. J. (1998). Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma, Histopathology 32, 20-7. |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies